Rubel, D.; Boulanger, J.; Craciun, F.; Xu, E.Y.; Zhang, Y.; Phillips, L.; Callahan, M.; Weber, W.; Song, W.; Ngai, N.;
et al. Anti-microRNA-21 Therapy on Top of ACE Inhibition Delays Renal Failure in Alport Syndrome Mouse Models. Cells 2022, 11, 594.
https://doi.org/10.3390/cells11040594
AMA Style
Rubel D, Boulanger J, Craciun F, Xu EY, Zhang Y, Phillips L, Callahan M, Weber W, Song W, Ngai N,
et al. Anti-microRNA-21 Therapy on Top of ACE Inhibition Delays Renal Failure in Alport Syndrome Mouse Models. Cells. 2022; 11(4):594.
https://doi.org/10.3390/cells11040594
Chicago/Turabian Style
Rubel, Diana, Joseph Boulanger, Florin Craciun, Ethan Y. Xu, Yanqin Zhang, Lucy Phillips, Michelle Callahan, William Weber, Wenping Song, Nicholas Ngai,
and et al. 2022. "Anti-microRNA-21 Therapy on Top of ACE Inhibition Delays Renal Failure in Alport Syndrome Mouse Models" Cells 11, no. 4: 594.
https://doi.org/10.3390/cells11040594
APA Style
Rubel, D., Boulanger, J., Craciun, F., Xu, E. Y., Zhang, Y., Phillips, L., Callahan, M., Weber, W., Song, W., Ngai, N., Bukanov, N. O., Shi, X., Hariri, A., Husson, H., Ibraghimov-Beskrovnaya, O., Liu, S., & Gross, O.
(2022). Anti-microRNA-21 Therapy on Top of ACE Inhibition Delays Renal Failure in Alport Syndrome Mouse Models. Cells, 11(4), 594.
https://doi.org/10.3390/cells11040594